Ribomic Inc.

2026/08/21 Updated
Market Cap: $28.5M (¥4.5B)
Stock Price: $0.51 (¥81)
Exchange Rate: 1 USD = ¥158.98

Supplementary description on the design and safety of a domestic Phase III clinical trial of achondroplasia treatment drug (umedaptanib pegol)

Importance:
Page Updated: July 1, 2026
IR Disclosure Date: July 1, 2026
その他

G-リボミック

Company overview · Stock price · Financial data · All IR

View company page →